Litcius/Paper detail

Repurposing metformin as adjuvant therapy in patients with ulcerative colitis treated with mesalamine: A randomized controlled double-blinded study

Sahar M El-Haggar, Sahar K. Hegazy, M Maher, Monir M. Bahgat, Mostafa M. Bahaa

2024International Immunopharmacology25 citationsDOI

Topics & Concepts

MedicineUlcerative colitisRepurposingMetforminInternal medicineRandomized controlled trialAdjuvantAdjuvant therapyDouble blindedColitisGastroenterologyChemotherapyInsulinPathologyDiseaseAlternative medicineEcologyBiologyPlaceboInflammatory Bowel DiseaseSphingolipid Metabolism and SignalingMetabolism, Diabetes, and Cancer
Repurposing metformin as adjuvant therapy in patients with ulcerative colitis treated with mesalamine: A randomized controlled double-blinded study | Litcius